Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

ADS Declares $0.20 Dividend, Reports Q2 FY2026 Results

Advanced Drainage Systems, Inc. filed a Form 8-K with the SEC on November 5, 2026, disclosing unaudited fiscal second-quarter results for the period ended September 30, 2026, announcing a quarterly cash dividend, and providing a Regulation FD presentation.

Shwetambri Chauhan | 05 November 2026

Lincoln International Q3 2026 Revenue Hits Record $293.7M

Lincoln International, Inc. filed an 8-K earnings press release on November 5, 2026, reporting third-quarter and year-to-date financial results for the period ended September 30, 2026.

Vinay Lochav | 05 November 2026

MSC Income Fund Declares Q1 2027 Dividends Plus $0.03 Supplemental

MSC Income Fund, Inc. filed an 8-K press release on November 5, 2026, announcing that its Board of Directors declared regular monthly cash dividends of $0.11 per share for each of January, February, and March 2027, along with a supplemental cash dividend of $0.03 …

Shwetambri Chauhan | 05 November 2026

Tripadvisor CEO Matt Goldberg to Depart by February 2027

Tripadvisor, Inc. (NASDAQ:TRIP) announced on November 5, 2026, that CEO and Board member Matt Goldberg will depart the company, and that CFO Michael Noonan separately plans to resign, triggering an interim leadership arrangement effective January 1, 2027.

Aakashdeep | 05 November 2026

Wheels Up Adds $100M Delta Credit Line, Orders Six Phenom 300E Jets

Wheels Up Experience Inc. filed a Form 8-K on November 5, 2026, disclosing that on November 4, 2026 the company entered into Amendment No. 6 to its existing Credit Agreement to add a $100.0 million revolving credit facility provided by Delta Air Lines, and …

Manish Choudhary | 05 November 2026

Peloton Q1 FY2027 Earnings Results Filed November 5

Peloton Interactive, Inc. filed a Form 8-K with the SEC on November 5, 2026, announcing financial results for the quarter ended September 30, 2026, alongside a conference call and press release on the same date.

Shwetambri Chauhan | 05 November 2026

Precision BioSciences ELIMINATE-B Advances to Phase 2

Precision BioSciences, Inc. filed a Form 8-K with the SEC on November 5, 2026, disclosing clinical trial updates for its PBGENE-HBV and PBGENE-DMD programs, including the advancement of the ELIMINATE-B study to Phase 2 and an eight-week safety observation for the first FUNCTION-DMD patient.

Nitish Kishor | 05 November 2026

Genprex REQORSA TUSC2 Aging Data Presented at GSA 2026

Genprex, Inc. filed a Form 8-K on November 5, 2026, disclosing a press release announcing translational analysis results from patients treated with its lead drug candidate, Reqorsa (quaratusugene ozeplasmid), presented at the Gerontological Society of America 2026 Annual Scientific Meeting.

Aditi Sarkar | 05 November 2026

Teleflex Q3 2026 Earnings Results Filed November 5

Teleflex Incorporated filed an 8-K current report on November 5, 2026, announcing financial results for the quarter ended September 30, 2026, via a press release and an accompanying earnings conference call slide presentation.

Vinay Lochav | 05 November 2026

N-able Files 8-K for Q3 2026 Earnings Release

N-able, Inc. filed a Form 8-K with the SEC on November 5, 2026, reporting the issuance of a press release covering its financial results for the third quarter ended September 30, 2026.

Vinay Lochav | 05 November 2026
Support

Hi! How can we help you today?

Loading…